Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
ARQT holding history
Arcutis Biotherapeutics, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −24,008−100.0% | Sold out | Holders |
| Q2 2025 | 24,008 | $336.6K | <0.1% | −11,692−32.8% | Reduced | Holders |
| Q1 2025 | 35,700 | $558.3K | <0.1% | −3,800−9.6% | Reduced | Holders |
| Q4 2024 | 39,500 | $550.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 39,500 | $367.4K | <0.1% | +22,000+125.7% | Added | Holders |
| Q2 2024 | 17,500 | $162.8K | <0.1% | +17,500 | New | Holders |